Skip to main content

Dr. Joseph M. Haggerty, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
44
In the NPI registry since
2006
Medicare patients seen, 2024
490

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1982Medical school: Virginia Commonwealth University, School of Medicine
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    MD license D0032407

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Medicare patients and services

Medicare patients, 2024
490
Services billed
83,659
Patients’ average age
77
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, darbepoetin alfa, 1 microgram (non-esrd use)33,64058
Injection, ferric carboxymaltose, 1 mg21,75024
Injection, daratumumab, 10 mg and hyaluronidase-fihj13,32019
Injection, aprepitant, 1 mg7,54031
Injection, azacitidine, 1 mg7,20014
Injection, pembrolizumab, 1 mg6,80018
Injection, iron sucrose, 1 mg5,30013
Injection, denosumab, 1 mg3,54018
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count1,601361
Blood test, comprehensive group of blood chemicals1,515347

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 1 companies reported 1 payments worth $36.57 in total to this clinician.

By company
Array Biopharma Inc$36.57
By type
Food and Beverage$36.57

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Maryland →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,031 in research payments for these studies, mostly to the institutions running them.

  • A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination With Everolimus or Pembrolizumab Versus Sunitinib Alone in First-Line Treatment of Subjects With Adv…
    Eisai Inc.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Rockville

Sources

NPI registry (CMS NPPES, November 2026; record last updated June 9, 2010), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1013098870. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.